MedBen Rx clients can save between 10-30% by using comparative effectiveness focusing on the best drug outcomes. One way it does this is by dispelling the costly misperception that “new is better.”
“A new FDA approved drug doesn’t mean it’s better than existing drugs,” noted MedBen President & CEO Kurt Harden at a recent MedBen University roundtable.” All FDA approval means is that a drug must show ‘statistical significance’ compared to a placebo.” Harden added that the power of commercial advertising and the lure of big rebates have placed less effective, higher cost drugs on the preferred drug list of many PBMs.
Through the use of evidence-based research, comparative effectiveness provides members with the most effective drugs at the best cost… so you can be certain that you’re getting maximum value from your pharmacy spend.
Find out more about comparative effectiveness and other MedBen Rx pharmacy solutions by calling 888-627-8683 or visiting